ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Thiamylal
  • indication:Used for the production of complete anaesthesia of short duration, for the induction of general anaesthesia, and for inducing a hypnotic state.
  • pharmacologypharmacology:
  • mechanism: Thiamylal binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.
  • toxicity: Intravenous LD50 in rat is 51 mg/kg.
  • absorprion: Rapidly absorbed (high lipid solubility).
  • halflife: Although no studies have been performed on humans, the half-life in cats is 14.3 hours.
  • roouteelimination:
  • volumedistribution:
  • clearance: